Related Experiment Video
Updated: Jun 27, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Seeking alternative biological therapies: the future of targeted molecular treatment
Jochen H Lorch1, Marshall R Posner, Lori J Wirth
1Dana Farber Cancer Institute, 44 Binney Street, SW430, Boston, MA 02115, USA. Jochen_Lorch@dfci.harvard.edu
Abstract:
In recent years targeted therapies have expanded treatment options for patients with squamous cell cancer of the head and neck (SCCHN) considerably and have led to clinically significant benefit. However, the multitude of new targeted drugs that have emerged and are in development also represent a challenge and many years of carefully conducted clinical studies will be needed to explore their full potential. This article summarizes the most important recent developments in the targeted treatment of SCCHN and provides an overview of pathways and promising potential targets that could impact the treatment of patients with SCCHN in the future.
Insights
Targeted therapies offer significant benefits for squamous cell cancer of the head and neck (SCCHN) patients. Ongoing research explores new drugs and targets to further advance SCCHN treatment strategies.
Area of Science:
- Oncology
- Head and Neck Cancer Research
Background:
- Targeted therapies have recently improved treatment outcomes for squamous cell cancer of the head and neck (SCCHN).
- The increasing number of novel targeted drugs presents both opportunities and challenges in clinical practice.
Purpose of the Study:
- To summarize recent advancements in targeted therapies for SCCHN.
- To provide an overview of potential future targets and pathways for SCCHN treatment.
Main Methods:
- Review of recent clinical studies and drug development in SCCHN.
- Analysis of emerging targeted pathways and molecular targets.
Main Results:
- Significant clinical benefits observed with current targeted therapies in SCCHN.
- Identification of several promising pathways and targets for future investigation.
Conclusions:
- Targeted therapies have substantially expanded treatment options for SCCHN.
- Further clinical studies are essential to fully realize the potential of new targeted drugs and targets in SCCHN management.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Microorganisms in Medicine and Therapeutics
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...